Skip to main content
Skip to main content
ADUS logo

Addus HomeCare Corporation (ADUS) Stock Analysis

$120.55 +$0.53 (+0.44%) |Exceptional · 92
Addus HomeCare Corporation (ADUS) bottom line: signals are mixed — the Council read leans Strongly Bullish (78/100) while the AI fundamental score is 92/100 (grade A+); the two lenses disagree, so weigh the breakdown below. Strongest single signal: Ray Dalio bullish.
MCap: $2.25B| P/E Ratio: 12.3| Vol: 230.8K| Target: $125.50 (+4.1%)| 52-wk range: $88.96 – $124.44
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Addus HomeCare Corporation (ADUS) trades at $120.55 with AI Score 92/100 (Grade A+). Addus HomeCare Corporation provides personal care, hospice, and home health services to individuals in the United States. Market cap: $2.25B, Sector: Healthcare.

Price as of Aug 21, 2026 · Last analyzed: May 10, 2026
Addus HomeCare Corporation provides personal care, hospice, and home health services to individuals in the United States. The company operates through 206 offices across 22 states, focusing on elderly, chronically ill, and disabled persons.

ADUS stock analysis for 2026: Analysts have set a consensus price target of $125.50 for Addus HomeCare Corporation, suggesting 4.1% upside from the current price of $120.55. The AI MoonshotScore is 92/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Watch the ADUS film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Strongly Bullish 78/100 · A

ADUS: 3/3 scored disciplines lean bullish. Dominant signal: Ray Dalio bullish.

How is this calculated? →
MoonshotScore · Growth Potential · 92/100
Business Quality
Strong Is this a genuinely good business?
Financial Safety
Moderate Could this blow up on me?
Valuation
Strong Am I paying a fair price?
Growth Durability
Strong Is the growth real and likely to last?
Momentum
Moderate Is the market already moving on this?
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Bullish
Jim Simons
Neutral
Izzy Englander
Bullish
Seth Klarman
Bullish
Moon AI
Bullish
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Moderate
Margin of Safety
Undervalued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Addus HomeCare Corporation (ADUS) Healthcare & Pipeline Overview

CEOR. Dirk Allison
Employees6,165
HeadquartersFrisco, TX, US
IPO Year2009

Addus HomeCare Corporation delivers personal care, hospice, and home health services, primarily catering to elderly and disabled individuals across the United States. Operating in a fragmented market, Addus distinguishes itself through a diversified service portfolio and a presence in multiple states, addressing the growing demand for in-home care solutions.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for ADUS?

As of May 10, 2026 — figures reflect the data available on that date.

Addus HomeCare Corporation presents a compelling investment case driven by the increasing demand for in-home care services due to the aging population and the growing preference for receiving care in a home setting. With a market capitalization of $2.25B and a P/E ratio of 12.3, Addus demonstrates financial stability and growth potential. The company's diversified service offerings across personal care, hospice, and home health segments provide resilience against market fluctuations. A gross margin of 32.5% and a profit margin of 6.9% indicate efficient operations. Key growth catalysts include strategic acquisitions and expansion into new geographic markets. However, potential risks include regulatory changes and labor shortages in the healthcare industry. The company's free cash flow of $0.07 billion provides financial flexibility for future investments and acquisitions.

Based on FMP financials and quantitative analysis

ADUS Key Highlights

Market Cap of $2.25B reflects substantial investor confidence in Addus's market position.

  • P/E Ratio of 12.3 suggests that the company is reasonably valued compared to its earnings.
  • Gross Margin of 32.5% indicates efficient cost management in service delivery.
  • Profit Margin of 6.9% demonstrates the company's ability to generate profits from its revenue streams.
  • Operations across 206 offices in 22 states provide a diversified geographic footprint, reducing reliance on any single market.

Who Are ADUS's Competitors?

ADUS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
LHCG LHC Group, Inc. $169.81 +0.00% $5.29B 45
AMCR Amcor plc $48.45 +1.33% $22.4B 44
CHE Chemed Corporation $534.88 -0.15% $6.99B 83
MD Pediatrix Medical Group, Inc. $26.22 +0.00% $2.15B 90
EXETF Extendicare Inc. $22.21 -2.72% $2.11B 54
SEM Select Medical Holdings Corporation $16.51 -0.09% $2.05B 63
ASTH Astrana Health, Inc. $38.74 -1.68% $1.92B 78
AMEH Apollo Medical Holdings, Inc. $40.82 -2.11% $1.83B 55

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ADUS's Key Strengths?

Diversified service offerings across personal care, hospice, and home health.

  • Established presence in multiple states.
  • Strong relationships with payor clients.
  • Experienced management team.

What Are ADUS's Weaknesses?

Exposure to regulatory changes and reimbursement pressures.

  • Labor shortages in the healthcare industry.
  • Dependence on government funding.
  • Competition from other national and regional providers.

What Could Drive ADUS Stock Higher?

Demographic trends indicate an aging population, driving increased demand for home healthcare services.

  • Potential acquisitions of smaller home healthcare providers to expand market share by Q4 2026.
  • Increasing adoption of value-based care models, incentivizing home-based care solutions.
  • Technological advancements in remote patient monitoring and telehealth, enhancing service delivery.

What Are the Key Risks for ADUS?

Changes in government regulations and reimbursement policies could negatively impact revenue.

  • Labor shortages in the healthcare industry may increase operating costs and limit service capacity.
  • Economic downturn could reduce consumer spending on discretionary healthcare services.
  • Competition from other national and regional home healthcare providers may erode market share.

What Are the Growth Opportunities for ADUS?

  • Expansion into New Geographic Markets: Addus has the opportunity to expand its presence into new states and regions, leveraging its established infrastructure and expertise. The company can target areas with a high concentration of elderly population and limited access to home healthcare services. This expansion can be achieved through strategic acquisitions or organic growth, increasing the company's market share and revenue streams. The market size for untapped geographic regions is estimated to be $50 billion by 2030.
  • Strategic Acquisitions: Addus can pursue strategic acquisitions of smaller home healthcare providers to expand its service offerings and geographic reach. Acquisitions can provide access to new markets, technologies, and talent, accelerating the company's growth trajectory. The company can focus on acquiring companies with complementary service lines or a strong presence in attractive geographic areas. The market for home healthcare acquisitions is estimated to be $20 billion annually.
  • Increased Focus on Technology: Addus can invest in technology solutions to improve operational efficiency, enhance patient care, and reduce costs. This includes implementing electronic health records (EHRs), telehealth platforms, and remote monitoring devices. Technology can enable the company to provide more personalized and proactive care, improving patient outcomes and satisfaction. The market for healthcare technology is projected to reach $400 billion by 2027.
  • Development of Specialized Care Programs: Addus can develop specialized care programs for specific patient populations, such as individuals with Alzheimer's disease, Parkinson's disease, or other chronic conditions. These programs can provide tailored care solutions that address the unique needs of these patients, improving their quality of life and reducing healthcare costs. The market for specialized care programs is estimated to be $30 billion by 2025.
  • Partnerships with Healthcare Providers: Addus can form partnerships with hospitals, physician groups, and other healthcare providers to integrate its services into the broader healthcare ecosystem. These partnerships can enable the company to provide seamless care transitions, improve patient outcomes, and reduce hospital readmissions. The market for healthcare partnerships is estimated to be $15 billion annually.

What Are ADUS's Competitive Advantages?

  • Diversified service offerings across personal care, hospice, and home health segments.
  • Established presence in multiple states, providing a broad geographic reach.
  • Strong relationships with governmental agencies, managed care organizations, and commercial insurers.
  • Reputation for providing high-quality care and customer service.

What Does ADUS Do?

Founded in 1979 and headquartered in Frisco, Texas, Addus HomeCare Corporation has evolved into a significant provider of home-based care services in the United States. The company operates through three primary segments: Personal Care, Hospice, and Home Health. The Personal Care segment offers non-medical assistance with activities of daily living, including bathing, grooming, meal preparation, and transportation. The Hospice segment provides palliative care, social work, spiritual counseling, and bereavement services for terminally ill patients and their families. The Home Health segment delivers skilled nursing, physical therapy, occupational therapy, and speech therapy to individuals recovering from illness or hospitalization. Addus serves a diverse range of payor clients, including governmental agencies, managed care organizations, commercial insurers, and private individuals. As of December 31, 2021, Addus operated through 206 offices in 22 states, reflecting its commitment to providing accessible and comprehensive care solutions to a growing population in need of in-home support.

What Products and Services Does ADUS Offer?

  • Provides non-medical personal care services, including assistance with bathing, dressing, and meal preparation.
  • Offers hospice care for terminally ill patients, including palliative nursing, social work, and spiritual counseling.
  • Delivers skilled nursing and therapy services in the home, such as physical, occupational, and speech therapy.
  • Assists with medication reminders and management.
  • Provides transportation services for medical appointments and errands.
  • Offers homemaking services, including light housekeeping and laundry.
  • Provides bereavement counseling for families of hospice patients.

How Does ADUS Make Money?

  • Generates revenue through fees for personal care, hospice, and home health services.
  • Contracts with federal, state, and local governmental agencies to provide services to eligible individuals.
  • Partners with managed care organizations and commercial insurers to provide services to their members.
  • Receives payments directly from private individuals for services rendered.

What Industry Does ADUS Operate In?

Addus HomeCare operates within the expanding home healthcare industry, driven by an aging population and increasing preference for in-home care. The industry is characterized by fragmentation, with numerous regional and local providers. Key trends include the shift towards value-based care, increasing adoption of technology, and growing demand for specialized care services. Addus competes with other national and regional players, as well as local agencies. The company's diversified service offerings and geographic reach provide a competitive advantage in capturing market share. The U.S. home healthcare market is projected to reach $300 billion by 2028, reflecting a significant growth opportunity for companies like Addus.

Who Are ADUS's Key Customers?

  • Elderly individuals who require assistance with activities of daily living.
  • Chronically ill or disabled persons who need ongoing care and support.
  • Individuals who are at risk of hospitalization or institutionalization.
  • Terminally ill patients who require hospice care.
  • Families who need support and assistance in caring for their loved ones.
AI Confidence: 73% Updated: May 10, 2026

Addus HomeCare Corporation (ADUS) Valuation Context

Valued at $2.25B, ADUS is classified as a mid-cap stock. Relative to its peer group, ADUS's quantitative score of 92/100 is above the peer average of 63/100.

ADUS Revenue & Earnings Trend

In Q2 2026, ADUS generated $377.4M in top-line revenue, marking a sequential increase of 3.8%. The company recorded net income of $27.6M, with diluted EPS of $1.49. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Healthcare. Across the four most recent quarters, ADUS averaged $1.43 in diluted EPS.

Company Profile

Addus HomeCare Corporation operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Frisco, US. The company is led by CEO R. Dirk Allison. ADUS has traded publicly since 2009.

ROE 9%

Key Financial Metrics

Return on equity for Addus HomeCare Corporation stands at 9.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.3%, showing how much profit it generates from its asset base. ADUS trades at a trailing price-to-earnings ratio of 12.27, below the Healthcare sector average of ~23x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.83 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 6/9

Financial Health

Addus HomeCare Corporation's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 6.31 places it in the safe zone, indicating low near-term bankruptcy risk.

FY2026 est

Forward Outlook

Wall Street analysts project Addus HomeCare Corporation revenue of about $1.52B for fiscal 2026, with EPS near $7.04. The estimate reflects 10 contributing analysts.

ADUS Financials

Fundamental Snapshot

Revenue Growth (FY)
+23.2%
Net Income Growth (FY)
+30.3%
EPS Growth (FY)
+19.9%
Free Cash Flow Growth (FY)
-6.0%
P/E (TTM)
12.3
Return on Equity (TTM)
+9.4%
Current Ratio
1.8

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Diversified service offerings across personal care, hospice, and home health.
  • Established presence in multiple states.
  • Strong relationships with payor clients.
  • Experienced management team.

Bear Case

  • Exposure to regulatory changes and reimbursement pressures.
  • Labor shortages in the healthcare industry.
  • Dependence on government funding.
  • Competition from other national and regional providers.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 2026 $377M $28M $1.49
Q1 2026 $364M $25M $1.36
Q4 2025 $373M $30M $1.61
Q3 2025 $362M $23M $1.24

Based on FMP financials and quantitative analysis

ADUS Latest News

ADUS Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ADUS.

Price Targets

Consensus target: $125.50

ADUS MoonshotScore

92/100

What does this score mean?

The MoonshotScore rates ADUS 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Latest Addus HomeCare Corporation Analysis

Leadership: R. Dirk Allison

CEO

R. Dirk Allison serves as the Chief Executive Officer of Addus HomeCare Corporation, bringing extensive experience in healthcare management and finance. His career includes leadership roles in various healthcare organizations, demonstrating a consistent track record of driving growth and operational efficiency. Allison's expertise spans strategic planning, financial management, and business development within the healthcare sector. His leadership is characterized by a focus on innovation and patient-centered care, positioning Addus for continued success in the evolving home healthcare landscape.

Track Record: Under R. Dirk Allison's leadership, Addus HomeCare Corporation has experienced significant growth through strategic acquisitions and organic expansion. He has overseen the successful integration of acquired companies, enhancing the company's service offerings and geographic reach. Allison has also focused on improving operational efficiency and enhancing the company's financial performance, contributing to increased shareholder value.

Addus HomeCare Corporation Healthcare Stock: Key Questions Answered

What does the AI Score mean for ADUS?

ADUS holds an AI Score of 92/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. Addus HomeCare Corporation provides personal care, hospice, and home health services to individuals in the United States. The company operates through 206 offices across 22 states, focusing …

What does Addus HomeCare Corporation do?

Addus HomeCare Corporation provides a range of in-home care services, including personal care, hospice care, and home health services. The company focuses on serving elderly, chronically ill, and disabled individuals who require assistance with activities of daily living, palliative care, or skilled nursing and therapy.

What do analysts say about ADUS stock?

Analyst consensus on Addus HomeCare Corporation (ADUS) reflects a generally positive outlook, driven by the company's strong market position and growth prospects in the expanding home healthcare industry. Key valuation metrics, such as the P/E ratio of 12.3, suggest that the stock is reasonably valued compared to its earnings.

What are the main risks for ADUS?

Addus HomeCare Corporation faces several key risks that could impact its financial performance and growth prospects. Regulatory changes and reimbursement pressures pose a significant threat, as changes in government regulations and reimbursement policies could negatively affect the company's revenue. Labor shortages in the healthcare industry could increase operating costs and limit service capacity.

What are the key factors to evaluate for ADUS?

Addus HomeCare Corporation (ADUS) holds an AI score of 92/100 (high). P/E: 12.3x vs the S&P 500's ~20-25x. Analysts target $125.50 (+4%). Not financial advice.

How frequently does ADUS data refresh on this page?

ADUS's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven ADUS's recent stock price performance?

Addus HomeCare Corporation (ADUS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified service offerings across personal care, hospice, and home health. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider ADUS overvalued or undervalued right now?

Addus HomeCare Corporation (ADUS) trades at 12.3x earnings. Analysts target $125.50 (+4%) — near fair value. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research ADUS before investing?

Before investing in Addus HomeCare Corporation (ADUS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on data available as of 2026-05-10.
  • Future events and market conditions may impact the accuracy of this analysis.
Data Sources

Popular Stocks

More Stocks We Cover